Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04848051 · ClinicalTrials.gov registry record · NA
Implementing Fit Kit Colorectal Cancer (CRC) Screening in High Risk Populations
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 3,127
- Enrollment target
NCT04848051: Completed NA study, sponsored by Yale University.
NCT04848051 is a NA study that has completed, run by Yale University. The registered enrollment target is 3,127 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (123% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04848051, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,127 participants
- Enrollment target
Study Summary
The purpose of this study is to understand best strategies for engaging high risk populations in a primary care setting to improved adherence to colorectal cancer screening guidelines. The results will be used to identify best practices that are scalable to other high-risk populations who are due or overdue for colorectal cancer (CRC) screening.
Primary Outcome
The total number of participants that completed their colorectal cancer screening will be measured between the different arms
Interventions
- BEHAVIORAL CRC screening reminder
- BEHAVIORAL CRC Reminder & Short message
- BEHAVIORAL CRC Reminder and Navigation Program
- BEHAVIORAL CRC Reminder & CRC education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,127 participants |
| Start Date | 2021-10-12 |
| Est. Completion | 2022-11-21 |
| Phase | NA |
What the finished NCT04848051 record still lists
NCT04848051 is an interventional study that assigns participants to a tested intervention. Its 3,127 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (123% higher).
The record links to 0 conditions, and to 4 interventions - of which CRC screening reminder is the first listed.
NCT04848051 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04848051 about?
NCT04848051 is a clinical study titled "Implementing Fit Kit Colorectal Cancer (CRC) Screening in High Risk Populations". The purpose of this study is to understand best strategies for engaging high risk populations in a primary care setting to improved adherence to colorectal cancer screening guidelines. The results will be used to identify best practices that are scalable to other high-risk populations who are due or...
What is the current status of trial NCT04848051?
This trial is currently completed. It is a NA study. The enrollment target is 3,127 participants. The study started on 2021-10-12. Estimated completion is 2022-11-21.
What interventions are being tested in trial NCT04848051?
The interventions under investigation include: CRC screening reminder (BEHAVIORAL), CRC Reminder & Short message (BEHAVIORAL), CRC Reminder and Navigation Program (BEHAVIORAL), CRC Reminder & CRC education (BEHAVIORAL).
Who is sponsoring clinical trial NCT04848051?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04848051's enrollment target sits among peer trials
3,127 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05051722 · 3,110 participants
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- NCT06224205 · 3,150 participants · NA
Digital Detection of Dementia (D Cubed) Studies: D3
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI